HSandM Magazine

Menu
  • Home
  • Headlines
  • Top Articles
    • Executive Spotlights
    • Round Tables
    • Industry Trends
    • Talent Trends
    • Great Minds
    • Innovation Showcase
    • Top Industry Lists
  • Advertise
  • Agency Directory
  • Showcase your Innovations
  • FREE SUBSCRIPTION!
Menu

HSandM Magazine

Search

July/August2019

Latest stories

Why I Work In Healthcare

The Secret to Growth? Adapt Your Brand

Industry Trends: By the Numbers

More stories

  • in Motivideos

    MOTIVIDEOS

    by hsandm July 1, 2019, 12:00 am

  • in Great Minds

    Great Advice From Great Minds: Working With, Not Just For, Patients

    by hsandm July 1, 2019, 12:00 am

  • in Industry Trends

    Industry World Preview and Outlook to 2024

  • in Top Industry Lists

    MEDICAL DEVICE TOP 50

    by hsandm July 1, 2019, 12:00 am

  • in Executive Spotlight

    Raj Garg: A Healthcare Leader Shares His Views on the Industry’s Challenges

    by hsandm July 1, 2019, 12:00 am

Trending Now

  • Headlines

    185 Views0 Comments

    in Headlines

    Turnstone Biologics Acquires Novel Cell Therapy Platform

    New York, January 20 2021 (BUSINESS WIRE) — Turnstone Biologics Corp., a clinical-stage biotechnology company pioneering the development of cancer immunotherapies, today announced that it has acquired California-based Myst Therapeutics, a privately held biotechnology company focused on advancing novel T-cell therapies for solid tumors. The acquisition adds a pipeline of innovative TIL programs to Turnstone’s portfolio of oncolytic virus candidates. Financial terms were not disclosed. More

    by hsandm January 20, 2021, 6:14 pm

    Read More

  • Headlines

    387 Views0 Comments

    in Headlines

    DJO® Acquires Trilliant Surgical

    Dallas, TX , January 19 2021 (BUSINESS WIRE)–DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical®, a national provider of foot and ankle orthopedic implants. The acquisition of Trilliant Surgical’s leading product technologies and clinical efficacy supports DJO’s focused expansion into the adjacent high-growth $1 billion US foot and ankle market. More

    by hsandm January 19, 2021, 5:31 pm

    Read More

  • Headlines

    292 Views0 Comments

    in Headlines

    Thermo Fisher Scientific to Acquire Mesa Biotech for $450 Million

    Waltham, MA , January 19 2021 (prnewswire) — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million in cash upon the completion of certain milestones following the close of the transaction. More

    by hsandm January 19, 2021, 5:02 pm

    Read More

  • Headlines

    484 Views0 Comments

    in Headlines

    HealthTronics Names Bill Linder New Chief Executive Officer

    Austin, TX, January 13, 2021 (PRNewswire) — HealthTronics, an Austin-based provider of integrated, mobilized medical technologies and services, has named Bill Linder its new Chief Executive Officer. More

    by hsandm January 13, 2021, 5:49 pm

    Read More

  • Headlines

    682 Views0 Comments

    in Headlines

    STERIS to Buy Cantel for $4.6B

    Little Falls, NJ and Dublin, Ireland, January 12 2021 (Gobenewswire) — STERIS plc (NYSE: STE) (“STERIS” or the “Company”) and Cantel Medical Corp (NYSE:CMD) (“Cantel”) today announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers. More

    by hsandm January 12, 2021, 5:25 pm

    Read More

  • Headlines

    1.3k Views0 Comments

    in Headlines

    Backed by Bayer, Senti Biosciences Snags $105 Million in Series B Fundraising

    Leverkusen, Germany & South San Francisco, CA, January 6 2021 (Business Wire) — Leaps by Bayer and Senti Biosciences, Inc., a leading gene circuit company, today announced a USD 105 million Series B financing round. The financing was led by Leaps by Bayer, the impact investment arm of Bayer AG. Additional investors included Matrix Partners China, Mirae Asset Capital, Ridgeback Capital and Intel Capital as well as existing investors, including New Enterprise Associates (NEA), 8VC, Amgen Ventures and Lux Capital. More

    by hsandm January 6, 2021, 10:15 pm

    Read More

Categories

  • Agency Directory
  • Digital Magazine
  • Editorial Board
  • Executive Spotlight
  • Great Minds
  • Headlines
  • Industry Trends
  • Innovation Showcase
  • Leadership
  • Motivideos
  • Round Table
  • Talent Trends
  • Top Industry Lists
  • Uncategorized
  • Why I Work in Healthcare

© 2021 by CL Media, Inc.

  • Home
  • Contact us
  • GDPR Privacy policy
  • Privacy Policy
  • Terms of Use
  • Sign Up!
Back to Top
Close
  • Home
  • Headlines
  • Top Articles
    • Executive Spotlights
    • Round Tables
    • Industry Trends
    • Talent Trends
    • Great Minds
    • Innovation Showcase
    • Top Industry Lists
  • Advertise
  • Agency Directory
  • Showcase your Innovations
  • FREE SUBSCRIPTION!
  • facebook
  • twitter
  • instagram
  • pinterest
  • youtube

Log In

Sign In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Back to Login

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

To use social login you have to agree with the storage and handling of your data by this website. %privacy_policy%

Accept

Add to Collection

  • Public collection title

  • Private collection title

No Collections

Here you'll find all collections you've created before.